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Atrial fibrillation (AF) is a significant healthcare challenge and is considered a global 
pandemic, since prevalence rates have increased substantially1 and AF-related 
hospitalizations outnumber those of major cardiac conditions such as heart failure and 
myocardial infarction.2 AF confers an increased risk of stroke and mortality, thus AF needs to 
be detected to manage the arrhythmia, but more importantly to also prevent comorbidities 
and death.3 Sinus rhythm (SR) in a 10-second 12-lead ECG should not be deceptive to 
possible AF beyond this short monitoring time. Whilst silent or undetected AF is common, 
current screening methods are limited and demanding. Continuous monitoring by means of 
loop recorders is often indicated, particularly in case of embolic stroke with undetermined 
source (ESUS).4 Novel and user-friendly wearables to identify arrhythmias have emerged 
with recent digital advances: wearable ECG technology using automated 
photoplethysmography (ppg) algorithms have shown feasible and accurate cardiac rhythm 
detection and will aid in monitoring the dynamic burden of time spent in AF5, while mobile 
AF applications are available for patients and health care professionals, for education and 
guidance in management.6   
 Attia and colleagues aimed to develop and validate an artificial-enabled ECG (AI-ECG) 
using a trained neural network to detect the electrographic signature of AF during SR.7 
Structural changes in the atria predispose to atrial arrhythmias.8 Deducting AF in a SR ECG 
has been attempted previously, by using P-wave and PR interval traces to describe 
phenomena such as interatrial block.9 Here, Attia et al. hypothesised that the signature of 
AF due the structural changes in the atria, could be identified by a trained network, using a 
12-lead ECG recorded during SR. Rather than finding the needle in the haystack by 
prolonged monitoring, authors basically suggest that AI will be able to judge by looking at 
the haystack if it has a needle hidden in it. P-wave characteristics are likely to be picked up 
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by the network, but no criteria are predefined or revealed in retrospect. In total, almost 65 
million ECGs from a cohort of 210,414 patients ≥18 years with a least one 12-lead SR ECG 
from the Mayo Clinic ECG laboratory were used to develop, test and validate the network. 
The authors created three datasets: 1) a set (70% of patient cohort) to train the network; 2) 
a validation set to optimize the network; and 3) a testing set, to identify the ability of the AI-
ECG to detect AF. Mathematical performance of the network demonstrated an impressive 
area under the curve of the operating receiver curve of 0.90%, a sensitivity 82.3%, specificity 
83.5% and overall accuracy 83.4%.   
 There are several strengths of the approach taken by Attia and colleagues. Firstly, 
they used a large cohort of patients and consequent ECGs and prevented bias by dividing 
the patients over three datasets, demonstrating a robust approach. Their findings will be of 
clinical importance especially in identifying silent AF, and may have significant implications 
for secondary prevention of patients with ESUS in terms of providing appropriate oral 
anticoagulation to prevent recurrences of stroke. Furthermore, this approach may lead to a 
paradigm shift in recording SR rather than AF on an ECG, with a specific focus on identifying 
structural changes. However, false negatives may also be part of the outcomes and would 
prevent appropriate therapy. Moreover, the network has been tested to retrospectively 
identify AF rather than predicting AF. The AI-enabled algorithm would require further 
validation in a different patient cohort, testing a healthier out of hospital population, and 
rigorous prospective clinical trial assessment. Advanced refinement may be necessary 
before the network can be used for primary AF prediction. 
 In summary, Attia and colleagues are to be congratulated for their innovative 
approach and the thorough development and local validation of the AI-ECG. Since AI-
algorithms have recently reached ‘Cardiologist-level’ in diagnostic performance10, this AI-
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ECG interpretation is ground breaking by creating an algorithm to reveal the likelihood of AF 
in  ECGs showing SR.  
Notwithstanding the limitations, the network can support clinical decision making, 
helping to relieve the AF-related healthcare burden. Further improvement of available 
systems, as well as related research is warranted to optimize the identification of AF and 
appropriate management accordingly. Combining ECG algorithms with age, gender, clinical 
features and biomarkers11 may further improve identification of AF patients. Additionally, 
linking these variables with genetic markers12, AI enabled algorithms7 and smart monitoring 
by means of wearables5 to diagnose AF and quantify AF burden, promises a safer and more 
efficient prevention of AF-related complications. 
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